Back to 2025 Abstracts
Hold The Aspirin—Acetylsalicylic Acid Is Not Associated With Decreased Flap Failure Risk In Autologous Breast Reconstruction
Audrey K. Mustoe, BA, Maria J. Escobar-Domingo, MD, Agustin N. Posso, MD, Micaela J. Tobin, BA, Sarah J. Karinja, MD, Bernard T. Lee, MD, MPH, MBA.
Beth Israel Deaconess Medical Center, Boston, MA, USA.
PURPOSE: Using a large database, this study examined the impact of postoperative acetylsalicylic acid (ASA) use on autologous breast reconstruction complication rates.
METHODS:This study queried TriNetX, an electronic health database, in October 2024 for patients with breast cancer who had undergone autologous breast reconstruction. Patients were stratified into two groups; those who received ASA postoperatively and those who had not. Patients were propensity score matched for demographic information and comorbidities, including anticoagulant use. Complication rates were examined at post-operative days 1, 30 and 60.
RESULTS: TriNetX query and 1:1 propensity score matching revealed outcomes for 2,694 patients. Flap failure risk was similar between ASA users and non-users at POD1 (14 vs. 10, p = 0.414), POD30 (17 vs. 13, p = 0.460) and POD60 (25 vs. 16, p=0.155). DVT, vascular complication, hematoma, and mortality rates were also similar between groups at all timepoints. ASA users were more likely to experience post-operative wound complications at POD30 and 60, but not POD1. ASA users had a significantly higher risk of transfusion and a lower mean hemoglobin than non-users at all timepoints.
CONCLUSION: ASA use postoperatively was not associated with a decreased risk of flap failure in autologous breast reconstruction patients. This study casts doubt upon the utility of postoperative ASA use for thromboprophylaxis and warrants further investigation.
Back to 2025 Abstracts